EARTH CITY, Mon.–(BUSINESS WIRE)–Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic options for the treatment of orphan and rare diseases, announces its support for the inaugural Gene Therapy and Special Pharmacy Awareness Month, September 2022. included in the annual calendar of health observations and recognition days published by The Society for Health Care Strategy & Market Development (SHSMD) of the American Hospital Association and founded by its parent company, AscellaHealth Family of Companies.
Brandon Salke, Pharm.D., general manager and responsible pharmacist, Optime Care said, “The Optime Care team supports our customers with a deep understanding of rare disease conditions and tailor-made solutions, offering unique, tailored approaches to the specialty drug market access to programs – including proven payer strategies – every step of the way. Our collaborative approach to addressing unmet market needs helps patients overcome barriers to accessing specialized care and treatment.”
Optime Care was founded in 2015 to offer manufacturers an integrated, long-term strategic partnership to support patients with orphan, ultra-orphan and rare diseases.
Clinical trial through commercial distribution and throughout the product lifecycle
In-depth knowledge of specific disease states
Payer experience and expertise
Distribution Partnerships: Exclusive and Non-Exclusive
Patient service/HUB provider
Robust data delivery and reporting
“Pharmaceutical manufacturers looking to launch a drug for small populations of rare diseases choose to partner with Optime Care’s experienced, dedicated team,” continues Salke. “Our focus on rare diseases and personalized care programs maximizes the benefit of these new therapies. This is where our high-touch, patient-first model improves access to new products and improves the patient journey.”
Many of these rare disease treatments and gene therapies require high-touch capabilities such as specialized shipping and storage, detailed therapy protocols, and management of side effects. Salke explains, “Our pharmacists and patient care teams have the clinical skills needed to better manage patient populations with rare and orphan diseases for optimal adherence and adherence throughout the treatment journey.”
About Optime Care
OptimeCare, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a range of comprehensive services tailored to maximize the therapeutic potential of treating orphan and rare diseases. Our executive team has collaborated in launching and managing more than 40 orphan products and programs while consistently implementing the best branded services to the community. Our experience with small patient populations and our strategic partnership with AscellaHealth enhances our services and our ability to serve the specialty pharmacy market. Optime Care has dual accreditation from the Utilization Review Accreditation Commission (URAC) for specialty pharmacy compliance and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/